Patient-reported outcomes across phase 3 studies of baricitinib demonstrate statistically significant improvements in physical function and quality of life symptoms in patients with rheumatoid arthritis (RA)
Cleveland 19,
SOURCE Eli Lilly and Company Pivotal trials show treatment with baricitinib resulted in significant improvements in pain…